← All trials
NCT07234721
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 1, 2025
- Primary completion
- Mar 20, 2028
- Completion date
- Oct 30, 2028
- First posted
- Nov 18, 2025
- Last posted
- Nov 18, 2025
- Enrollment
- 9
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- China Academy of Chinese Medical SciencesLead sponsor
- Hebei Senlang Biotechnology Inc., Ltd.Collaborator
Drugs studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.